Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global ...

Eli Lilly and Co (NYSE:LLY) stock is trading higher after the company released better-than-expected fourth-quarter earnings ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes drug ...

Bernstein research firm maintained a positive outlook on Eli Lilly (NYSE:LLY) shares, reiterating an Outperform rating and a ...

Investing.com - Eli Lilly's (NYSE: LLY) full-year profit forecast largely surpassed Wall Street expectations on Thursday, as ...

Eli Lilly (LLY) investors should expect fireworks ... to reduced demand and cautious stocking by pharmacies, triggering stock price volatility amid lower revenue projections.

Eli Lilly (NYSE: LLY) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in this morning's Q4 earnings report. Heading into the report, analysts ...

Most analysts are forecasting only $22.69 per-share profit this year. With Lilly stock priced at about 37 times current year earnings, and still doubling those earnings every year, there's a ...

Eli Lilly (LLY) stock is higher Thursday after ... According to S&P Global Market Intelligence, the consensus analyst target price for LLY stock is $975.09, representing implied upside of about ...

The bottom line: We’re raising our fair value estimate to $620 ... which supports Lilly’s wide moat, but we think the market assigns the stock too high a premium, considering long-term ...